Human coronavirus OC43 serum inhibitor and neutralizing antibody by a new plaque-reduction assay

G. Gerna, E. Cattaneo, P. M. Cereda, M. G. Revelo, G. Achilli

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

A plaque-reduction assay for the determination of neutralizing antibody to human coronavirus OC43 has been set up, using as a plaquing factor the fetal calf serum containing an OC43 inhibitor. A similar inhibitor has also been found in human sera both negative and positive for OC43 antibody. The inhibitor can be removed by treatment of sera with phospholipase C and is likely to be a lipoprotein of the high density class. The new plaque-reduction assay appears to be a very sensitive test for both OC43 antibody determination and serodiagnosis of OC43 infections. It may also be very useful for studies of antigenic relationships between human and animal coronaviruses. However, before testing, sera must be routinely treated for removal of viral inhibitor.

Original languageEnglish
Pages (from-to)360-366
Number of pages7
JournalProceedings of the Society for Experimental Biology and Medicine
Volume163
Issue number3
Publication statusPublished - 1980

Fingerprint

Human Coronavirus OC43
Neutralizing Antibodies
Assays
Antibodies
Type C Phospholipases
HDL Lipoproteins
Serum
Animals
Coronavirus
Testing
Serologic Tests
Infection

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Human coronavirus OC43 serum inhibitor and neutralizing antibody by a new plaque-reduction assay. / Gerna, G.; Cattaneo, E.; Cereda, P. M.; Revelo, M. G.; Achilli, G.

In: Proceedings of the Society for Experimental Biology and Medicine, Vol. 163, No. 3, 1980, p. 360-366.

Research output: Contribution to journalArticle

@article{5d7885c1ec56425797f9812600802b7d,
title = "Human coronavirus OC43 serum inhibitor and neutralizing antibody by a new plaque-reduction assay",
abstract = "A plaque-reduction assay for the determination of neutralizing antibody to human coronavirus OC43 has been set up, using as a plaquing factor the fetal calf serum containing an OC43 inhibitor. A similar inhibitor has also been found in human sera both negative and positive for OC43 antibody. The inhibitor can be removed by treatment of sera with phospholipase C and is likely to be a lipoprotein of the high density class. The new plaque-reduction assay appears to be a very sensitive test for both OC43 antibody determination and serodiagnosis of OC43 infections. It may also be very useful for studies of antigenic relationships between human and animal coronaviruses. However, before testing, sera must be routinely treated for removal of viral inhibitor.",
author = "G. Gerna and E. Cattaneo and Cereda, {P. M.} and Revelo, {M. G.} and G. Achilli",
year = "1980",
language = "English",
volume = "163",
pages = "360--366",
journal = "Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)",
issn = "0037-9727",
publisher = "SAGE Publications Ltd",
number = "3",

}

TY - JOUR

T1 - Human coronavirus OC43 serum inhibitor and neutralizing antibody by a new plaque-reduction assay

AU - Gerna, G.

AU - Cattaneo, E.

AU - Cereda, P. M.

AU - Revelo, M. G.

AU - Achilli, G.

PY - 1980

Y1 - 1980

N2 - A plaque-reduction assay for the determination of neutralizing antibody to human coronavirus OC43 has been set up, using as a plaquing factor the fetal calf serum containing an OC43 inhibitor. A similar inhibitor has also been found in human sera both negative and positive for OC43 antibody. The inhibitor can be removed by treatment of sera with phospholipase C and is likely to be a lipoprotein of the high density class. The new plaque-reduction assay appears to be a very sensitive test for both OC43 antibody determination and serodiagnosis of OC43 infections. It may also be very useful for studies of antigenic relationships between human and animal coronaviruses. However, before testing, sera must be routinely treated for removal of viral inhibitor.

AB - A plaque-reduction assay for the determination of neutralizing antibody to human coronavirus OC43 has been set up, using as a plaquing factor the fetal calf serum containing an OC43 inhibitor. A similar inhibitor has also been found in human sera both negative and positive for OC43 antibody. The inhibitor can be removed by treatment of sera with phospholipase C and is likely to be a lipoprotein of the high density class. The new plaque-reduction assay appears to be a very sensitive test for both OC43 antibody determination and serodiagnosis of OC43 infections. It may also be very useful for studies of antigenic relationships between human and animal coronaviruses. However, before testing, sera must be routinely treated for removal of viral inhibitor.

UR - http://www.scopus.com/inward/record.url?scp=0018827886&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0018827886&partnerID=8YFLogxK

M3 - Article

C2 - 6244598

AN - SCOPUS:0018827886

VL - 163

SP - 360

EP - 366

JO - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

JF - Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine (New York, N. Y.)

SN - 0037-9727

IS - 3

ER -